Combination of entinostat with anti-PD-1 antibody enhanced the ICB antitumor effect in two syngeneic tumor mouse models by reducing tumor growth and neutralizing both M-MDSC and PMN-MDSC populations (Orillion et al., 2017). This evidence concerns the gene PDCD1 and neoplasm.